Stockreport

Aclaris Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
PDF Net loss: US$132.1m (loss widened by 49% from FY 2023). US$1.71 loss per share (further deteriorated from US$1.27 loss in FY 2023). ACRS Products In Clinical Trials [Read more]